About Us

Mission

The mission of this website is to inform the public about the safe and effective use of stem cell therapy in various medical conditions by presenting published data from human clinical trials. It will act as a resource for all interested parties to be informed by objective data rather than hearsay or conjecture.

Our goal is to increase awareness of the safety and efficacy of stem cell therapy in order to provide patients with an additional, viable treatment option. Based on the early human clinical trials there appears to be a strong argument for the use of stem cell therapy in the treatment of various medical conditions. While we wait for phase II/III trials the current data is encouraging and supports use of stem cell therapy in the clinical setting.

Methods

We highlight selected studies demonstrating the safety and efficacy of stem cell therapy in various common medical conditions. Studies were selected based on the commonality of the medical condition, publication date, type of stem cells and route of administration. PubMed and Google Scholar were used to search for human clinical studies published within the past 5 years that investigated bone marrow, umbilical cord or adipose tissue derived stem cells. We focused on studies that primarily used intra-articular injection and or intravenous infusion. For additional evidence we included systematic reviews/meta-analyses involving other stem cell types and routes of administration.

About Dr. Ahvie Herskowitz

Dr. Herskowitz’s extensive training includes a medical degree from The Albert Einstein College of Medicine, residencies in Anatomic Pathology and Internal Medicine, and Fellowship training in Cardiology at The Johns Hopkins Medical Center. During his 12 years at Johns Hopkins, he became Associate Professor of Medicine and Immunology and Molecular Microbiology and led a research team in the study of molecular and immunological mechanisms of inflammation, autoimmunity, ischemia, heart transplantation rejection and congestive heart failure.

Over the past 15 years, he helped establish and lead innovative health care non-profit research and development organizations that have domestic and worldwide social impact. He was head of a 75-person research team at the Ischemia Research and Education Foundation, working with over 100 leading heart surgery hospitals around the world, reducing adverse outcomes during and after heart surgery. Since 1999, he has been Clinical Professor of Medicine at University of California at San Francisco, and Co-founder and Chief Medical Officer of the Institute for OneWorld Health, the first non-profit pharmaceutical company in the United States. He is President of the American College for Advancement in Medicine (ACAM), one of the most respected Integrative Medicine societies in the US; Chairman of the Board of Directors for iRND3, an organization that discovers new medicines for rare and neglected diseases, and serves on the Board for the Pulmonary Vascular Research Institute (PVRI).

In 2010, he formed Anatara Medicine, based in San Francisco, to provide a world-class integrative medicine team approach towards prevention and treatment of vascular, immunologic, and difficult chronic diseases. He is also Founder of the San Francisco Stem Cell Treatment Center. With over four decades of experience in Medicine, Cardiology, Immunology, Regenerative Medicine, and Pathology, Dr. Herskowitz is one of most senior academic, anti-aging doctors in the U.S.

Areas of Clinical Expertise

• Cardiovascular and Lung Disease
• Regenerative Medicine/Stem Cells
• Immunobiology, Inflammation and Mechanisms of Injury
• Advanced heart failure
• Coronary Artery Bypass Surgery and Cardiac Transplantation
• Anti-Aging and Preventive Medicine
• Genetic testing, immunogenetics
• Metabolomics
• Cancer Care Support
• Optimization (Performance and Prevention)
• Diabetes and Obesity/Weight Loss/Nutrition
• Chronic Conditions (i.e. Autoimmunity, infectious disease, diabetes, renal disease)
• Global Philanthropy and Health; Non-profit Sustainability & Strategic Planning